1). Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984; 132:474–9.
Article
2). Levy A, Samraj GP. Benign prostatic hyperplasia: when to'watch and wait,'when and how to treat. Cleve Clin J Med. 2007; 74(Suppl 3):S15–20.
3). De la Rosette J, Alivizatos G, Madersbacher S, Perachino M, Thomas D, Desgrandchamps F, et al. EAU guidelines on benign prostatic hyperplasia (BPH). Eur Urol. 2001; 40:256–63.
Article
4). Roehrborn CG, Bartsch G, Kirby R, Andriole G, Boyle P, de la Rosette J, et al. Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative, international overview. Urology. 2001; 58:642–50.
Article
5). Borboroglu PG, Kane CJ, Ward JF, Roberts JL, Sands JP. Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol. 1999; 162:1307–10.
Article
6). Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)–incidence, management, and prevention. Eur Urol. 2006; 50:969–79.
Article
7). Reich O, Gratzke C, Stief CG. Techniques and longterm results of surgical procedures for BPH. Eur Urol. 2006; 49:970–8.
Article
8). Malek RS, Kuntzman RS, Barrett DM. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol. 2000; 163:1730–3.
Article
9). Malek RS, Kuntzman RS, Barrett DM. Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on longterm outcomes. J Urol. 2005; 174:1344–8.
Article
10). Spaliviero M, Araki M, Wong C. Short-term outcomes of Greenlight HPS laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). J Endourol. 2008; 22:2341–7.
Article
11). Wong C, Araki M, Tonkin JB. High-power potassium-titanyl-phosphate or lithium triboride laser photoselective vaporization prostatectomy for benign prostatic hyperplasia: a systematic approach. J Endourol. 2007; 21:1141–4.
Article
12). Yu X, Elliott SP, Wilt TJ, McBean AM. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. J Urol. 2008; 180:241–5.
Article
13). Costello AJ, Bowsher WG, Bolton DM, Braslis KG, Burt J. Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol. 1992; 69:603–8.
Article
14). Ruszat R, Seitz M, Wyler SF, Muller G, Rieken M, Bonkat G, et al. Prospective single centre comparison of 120 W diode pumped solid state high intensity system laser vaporization of the prostate and 200 W high intensive diode laser ablation of the prostate for treating benign prostatic hyperplasia. BJU Int. 2009; 104:820–5.
15). Milam DF, Smith Jr JA. Urologic Laser Surgery. Gillenwater JY, Grayhack JT, Howards SS, Mitchell ME, editors. Adult and pediatric urology. 4th ed.Philadelphia: Lippincott Williams & Wilkins;2002. p. 291–317.
16). Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol. 2004; 172:1404–8.
Article
17). Bachmann A, Ruszat R, Wyler S, Reich O, Seifert HH, Muller A, et al. Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol. 2005; 47:798–804.
Article
18). Hwang CH, Cho CK, Lee YK, Hong SJ. Comparative analysis of short-term efficacy and complication of photoselective vaporization for benign prostatic hyperplasia which was classified by prostate size. Korean J Urol. 2007; 48:826–31.
Article
19). Park JS, Kim CS, Ahn H, You CH, Hong B, Ahn TY, et al. Comparison of treatment outcomes between photoselective vaporization and transurethral resection of the prostate for benign prostatic hyperplasia. Korean J Urol. 2007; 48:297–303.
Article
20). Ko DW, Jeong BC, Son H. Initial experiences with a new 120 W greenlightTM high-power system for photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia in Korea. Korean J Urol. 2009; 50:1089–94.
21). Bachmann A, Schurch L, Ruszat R, Wyler SF, Seifert HH, Muller A, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol. 2005; 48:965–71. discussion 972.
Article
22). Alivizatos G, Skolarikos A, Chalikopoulos D, Papachristou C, Sopilidis O, Dellis A, et al. Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80 ml: 12-mo results of a randomized prospective study. Eur Urol. 2008; 54:427–37.
23). Spaliviero M, Araki M, Culkin DJ, Wong C. Incidence, management, and prevention of perioperative complications of GreenLight HPS laser photoselective vaporization prostatectomy: experience in the first 70 patients. J Endourol. 2009; 23:495–502.
24). Ruszat R, Seitz M, Wyler SF, Abe C, Rieken M, Reich O, et al. GreenLight laser vaporization of the prostate: single-center experience and longterm results after 500 procedures. Eur Urol. 2008; 54:893–901.
Article